^
Association details:
Biomarker:ABCC1 overexpression
Cancer:Hepatocellular Cancer
Drug Class:Immunotherapy
Direction:Resistant
Evidence:
Evidence Level:
Resistant: C3 – Early Trials
New
Title:

ABCC1 is a predictive biomarker for prognosis and therapy in hepatocellular carcinoma

Excerpt:
This indicated that patients with a high expression of ABCC1 might respond poorly to immune checkpoint blockade (ICB) therapy (p = 9.2e-07).
DOI:
10.26355/eurrev_202304_32143